Will Dustin Moskovitz make additional open-market purchases of ASAN shares in H1 2026 (January-June)?

The stock crash to $7.60 significantly strengthens the YES case. Moskovitz bought at $18.16 (private placement) and $14-15 (open-market), so $7.60 represents a 47-58% discount to his historical purchase prices. For someone who takes $1 salary and has his wealth overwhelmingly concentrated in ASAN, this is the most compelling accumulation opportunity he has ever seen. The resolution bar remains extremely low — one purchase in 4 remaining months. The $200M buyback authorization is an indirect conviction signal but does not preclude personal buying; historically he has done both corporate buyback and personal purchases simultaneously.

The Q4 earnings update is net positive for this market. The $7.60 stock price creates extraordinary value-buying motivation for Moskovitz. However, I'm weighting the counter-argument more heavily: the $200M corporate buyback is a meaningful new channel for expressing conviction. Moskovitz may rationally prefer the tax-efficient corporate buyback route (which benefits all shareholders proportionally) over personal purchases that increase his already massive concentration risk. No new Form 4 filings noted in Q4 materials is a mildly negative signal — it suggests at least a temporary pause in personal buying. Still, with 4 months remaining and this price level, one purchase is very likely.

The critical update is the stock at $7.60 — a level that would represent extreme undervaluation from Moskovitz's perspective given his $18.16 private placement basis. The EXCESSIVE expectations classification from the earnings update further suggests the market has overreacted. Moskovitz has demonstrated willingness to buy into weakness repeatedly. The $200M buyback authorization he pushed through the board is additional conviction but serves a different purpose (reducing share count for all holders) than personal accumulation (increasing his economic exposure). Both can coexist. CFO departure is a minor negative but unlikely to affect Moskovitz's personal trading decisions. Trading window restrictions around the CFO transition could delay but not prevent a purchase within the 4-month window.

This is the strongest setup for Moskovitz personal buying we've seen. The stock at $7.60 is a 58% discount to his $18.16 private placement — if he believed ASAN was worth buying at $18.16, $14, and $15, the case at $7.60 is dramatically stronger. The $200M buyback authorization he championed through the board shows he hasn't lost conviction. The question asks for just ONE purchase in 4 months from someone with a multi-year buying pattern, $1 salary, stated investment intent, and who is looking at the cheapest ASAN shares of the decade. The probability of zero purchases approaches single digits.

The Q4 data shifts the probability upward from the initial 0.82 estimate. The stock at $7.60 dramatically increases value-buying motivation — Moskovitz would be buying at less than half his 2022 private placement price. The $200M buyback is the strongest indirect signal of continued conviction. However, I'm accounting for two real risks: (1) no new Form 4 filings were noted, suggesting a possible lull in personal buying, and (2) with $200M in corporate buyback authority, Moskovitz may genuinely prefer the corporate route. These risks are modest against the extremely low resolution threshold and 4-month window, but they prevent me from going above 0.85.

Framing this as: what is the probability that Moskovitz makes ZERO open-market purchases between now and June 30, 2026, with the stock at $7.60? Given his track record of buying at $14-18, his stated SC 13D/A investment intent, his $1 salary structure, and 58% voting control signaling deep engagement — the probability of complete cessation is very low. The $200M buyback is relevant but historically Moskovitz has done BOTH corporate buyback and personal buying. The CFO transition creates temporary uncertainty but Moskovitz's personal trades are independent of CFO activity. I see approximately 13% chance of NO, driven primarily by the possibility that he rationally shifts entirely to the corporate buyback channel.

Stock at $7.60 is the cheapest ASAN has been in Moskovitz's buying history — well below his $18.16 private placement and $14-15 open-market buys. With 4 months remaining, a multi-year buying pattern, $1 salary, and stated investment intent, one purchase is highly probable. The $200M buyback authorization reinforces conviction. The lack of new Form 4 filings is noted but not alarming given the narrow Q4 reporting window.

The earnings update is net positive for this market. Moskovitz has repeatedly demonstrated willingness to buy during price weakness, and $7.60 represents the deepest discount to his purchase history. The $200M buyback authorization shows continued engagement and conviction. Resolution requires only one purchase in 4 months. Main risk is a complete shift to corporate buyback channel, but this would be unprecedented — he has historically done personal buying alongside corporate repurchases.

While the stock crash to $7.60 strengthens the buying case, I'm weighting the counter-arguments more than other runs. The $200M corporate buyback is a substantial new channel — at $7.60, this buys back 26M+ shares, which is enormously accretive. Moskovitz as a rational capital allocator may genuinely prefer this route. Additionally, no new Form 4 filings were noted, and the CFO departure creates organizational complexity. However, even with these concerns, the multi-year pattern, low resolution threshold, and extreme price discount make YES still heavily favored.